1-5 of 5
Ian P Whitehead
Close
Sort by
Journal Articles

Examination of Clinically-Derived p210 BCR/ABL Rhogef Mutations in a Murine Bone Marrow Transplantation Model of CML

Bryan T. Ciccarelli, MD PhD, Tinghui Hu, PhD, Qing Wang, MD PhD, Julia J. Kim, MD, Ian P. Whitehead, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 24.
https://doi.org/10.1182/blood-2020-141685
Published: 2020
Journal Articles

Investigation Of p210 Bcr-Abl Rhogef Activity In The Progression Of Chronic Myelogenous Leukemia

Bryan T Ciccarelli, MA, Ilona Tala, PhD, Tinghui Hu, PhD, Dan Li, BS, Ru Chen, PhD, Qing Chen, PhD, Ian P Whitehead, PhD
Journal: Blood
Blood (2013) 122 (21): 3802.
https://doi.org/10.1182/blood.V122.21.3802.3802
Published: 2013
Journal Articles

Ubiquitin-mediated interaction of p210 BCR/ABL with β-catenin supports disease progression in a murine model for chronic myelogenous leukemia

Ru Chen, Tinghui Hu, Gwendolyn M. Mahon, Ilona Tala, Nicole L. Pannucci, Harvey L. Ozer, Ian P. Whitehead
Journal: Blood
Blood (2013) 122 (12): 2114–2124.
https://doi.org/10.1182/blood-2013-01-481184
Published: 2013
Includes: Supplemental data
Journal Articles

Ubiquitin-Mediated Binding and Stabilization of β-Catenin by p210 BCR/ABL.

Ru Chen, Gwen Mahon, Ian P Whitehead
Journal: Blood
Blood (2009) 114 (22): 3278.
https://doi.org/10.1182/blood.V114.22.3278.3278
Published: 2009
Journal Articles

Xeroderma Pigmentosum Group B Binding Contributes to p210 BCR/ABL Mediated Transformation in CML.

Nicole L Pannucci, Sutapa Sahay, Emily K Thomas, Ru Chen, Nicholas J Megjugorac, Homer C Adams, III, Pedro L Rodriguez, Ethan R Fitzpatrick, David A. Williams, MD, Ian P Whitehead
Journal: Blood
Blood (2008) 112 (11): 1087.
https://doi.org/10.1182/blood.V112.11.1087.1087
Published: 2008